EXAMS · SÃO PAULO
sFlt-1 and PlGF test: price, how it is done and uses
A blood test during pregnancy that helps your doctor assess the likelihood of preeclampsia with greater confidence.

Understand the exam
Preeclampsia is a pregnancy complication in which high blood pressure develops suddenly after 20 weeks, along with at least one other problem, such as protein loss in the urine, signs that other maternal organs have been affected, or changes in the placenta. It is linked to an imbalance: sFlt-1 rises in the mother's blood, and free PlGF falls.
PlGF, or placental growth factor, helps form blood vessels in the placenta. sFlt-1 acts in the opposite way and blocks the action of PlGF. That is why the doctor usually considers both measurements together and calculates their ratio.
At the clinic, you will find three names: Placental growth factor, PLGF, and SFLT-1 (soluble fms-like tyrosine kinase 1). The first two are names for the same substance. The doctor's order specifies whether you need only PlGF or PlGF together with sFlt-1.
How it is done
The test involves drawing blood from a vein in the arm with a thin needle. When both measurements are ordered, they usually come from the same blood draw.
The result is interpreted together with routine clinical assessment, and the doctor decides the next step in follow-up care.
When it is recommended
- Suspected preeclampsia between 20 weeks and 36 weeks and 6 days of pregnancy
- Headache or vision changes during pregnancy, which may be signs of preeclampsia
- Concern about the baby's growth, at the doctor's discretion
Does the exam hurt?
If you feel any discomfort during or after the blood draw, tell the team.
After the exam
Cost and health plans
| Exam | Self-pay | Duration | Health plans |
|---|---|---|---|
| PLGF | Starting at R$ 1,078.80 (≈ US$ 189, estimated) | Confirm with the team | Ask the team about coverage |
| Placental growth factor | From R$ 1,411.20 (≈ US$ 247, estimated) | Confirm with the team | Ask the team about coverage |
| SFLT-1 (soluble FMS-LIKE tyrosine kinase 1) | From R$ 1,776.00 (≈ US$ 310, estimated) | Confirm with the team | Ask the team about coverage |
The team confirms the requested option, coverage, and conditions before booking.
Book an examFrequently asked questions
What is the sFlt-1/PlGF ratio used for?
The ratio helps the doctor assess the likelihood of preeclampsia in people with suspected disease. A low value indicates that preeclampsia is unlikely in the short term.
Does the test confirm that I have preeclampsia?
Not on its own. The test is used together with routine clinical assessment to determine whether preeclampsia is present. The result is one more piece of information to help the doctor decide.
What is the difference between Placental growth factor, PLGF and SFLT-1?
Placental growth factor and PLGF are two names for the same measurement. SFLT-1 is a different substance, measured separately. To calculate the ratio, the doctor needs both: PlGF and sFlt-1.
At how many weeks can I have the test?
The test is indicated when preeclampsia is suspected between 20 weeks and 36 weeks and 6 days of pregnancy. Your obstetrician decides when to perform it.
Is fasting required?
The team explains preparation and visit duration when you schedule.
Does my health plan cover the sFlt-1 and PlGF test?
Check the table on this page for plans with coverage on record. If your health plan is not listed, the team will confirm coverage for you.
What is the price of the test?
The self-pay price for each measurement is in the pricing table on this page. The team will provide the turnaround time.
Where we see patients
References
- Verlohren S, Brennecke SP, Galindo A, et al. Clinical interpretation and implementation of the sFlt-1/PlGF ratio in the prediction, diagnosis and management of preeclampsia. Pregnancy Hypertens. 2022.
- Dimitriadis E, Rolnik DL, Zhou W, et al. Pre-eclampsia. Nat Rev Dis Primers. 2023.
- NICE. PLGF-based testing to help diagnose suspected preterm pre-eclampsia (DG49/HTG630). National Institute for Health and Care Excellence. 2022.
- Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003.
- NICE. PLGF-based testing to help diagnose suspected preterm pre-eclampsia — Information for the public. National Institute for Health and Care Excellence. 2022.
- Stepan H, Galindo A, Hund M, et al. Clinical utility of sFlt-1 and PlGF in screening, prediction, diagnosis and monitoring of pre-eclampsia and fetal growth restriction. Ultrasound Obstet Gynecol. 2023.
- Zeisler H, Llurba E, Chantraine F, et al. Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia. N Engl J Med. 2016.
- Miller EC, Vollbracht S. Neurology of Preeclampsia and Related Disorders: an Update in Neuro-obstetrics. Curr Pain Headache Rep. 2021.
This content is informational and does not replace a consultation.
Updated on